Post-Approval Regulatory Requirements

Winifred Werther () and Anita M. Loughlin ()
Additional contact information
Winifred Werther: Center for Observational Research
Anita M. Loughlin: Corrona LLC

Chapter 38 in Principles and Practice of Clinical Trials, 2022, pp 699-725 from Springer

Abstract: Abstract Health authorities throughout the world have regulations for requesting additional research in the post-approval setting. This chapter focuses on the regulations in the USA and European Union (EU). The history of post-approval studies can be traced through changing regulations enforced by the US Food and Drug Administration (FDA) and the EU European Medicines Agency (EMA). Post-approval studies are either clinical trials (interventional) or observational (non-interventional) studies. Choosing a study design may be influenced by the strengths and weaknesses of the design options and available data sources. Imposed post-approval studies are reviewed for compliance by the regulatory agencies. For clinical trials that are ongoing at the time of approval, often these are classified as post-marketing commitment (PMC) in the USA or post-authorization measure (PAM) in the EU. Findings of these trials can be submitted to the health authorities for addition to the prescribing information. The FDA and EMA both track progress on PMC/PMRs and PAMs, respectively. Post-approval studies are necessary to continually gather data on the safety and effectiveness of approved drugs. These studies are regulated by health authorities, included in registries (e.g., ClinicalTrials.gov, ENCePP), and tracked to completion. This chapter reviews the history of the regulations, terminology, study designs, and systematic reviews of the published post-approval studies.

Keywords: Post approval; Post marketing; Post authorization; Pharmacovigilance; Pharmacoepidemiologic (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-319-52636-2_256

Ordering information: This item can be ordered from
http://www.springer.com/9783319526362

DOI: 10.1007/978-3-319-52636-2_256

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().